Projects and Partners


Ima-Go: A High-throughput, Functional Imaging Platform to Accelerate Drug Discovery

The aim of this SME Instruments Phase 1 proposal is to perform a feasibility study for the commercialization of Ima-Go, a novel 96-well functional imaging platform for preclinical drug discovery for substances targeting brain diseases.

In contrast to state-of-the-art technologies for functional imaging, which either interfere with cellular viability and physiology or provide only a poor spatiotemporal resolution, Ima-Go is label-free, non-invasive and provides readouts of highest quality and resolution. The Ima-Go platform will introduce to the market new biological assays for human cell lines, which cannot be performed by current competing technologies.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 854430.




Albisriederstrasse 253
8047 Zurich, Switzerland

+41 44 244 24 24